Login
$SGRY
$23.36 +$0.00 (0.0%) After hours

$SGRY SEC Filings

Filed On Filing
27 Oct 2026 DEFA14A
26 Oct 2026 DEFA14A
26 Oct 2026 SCHEDULE 13D/A
26 Oct 2026 DEFA14A
26 Oct 2026 8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure

AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of October 23, 2026, by and among Surgery Partners, Inc., a Delaware corporation (the “Company”), Spyglass Topco, LLC, a Delaware limited liability company (“Parent”), Spyglass Me...

13 Oct 2026 SCHEDULE 13G
17 Sep 2026 8-K: Completion of Acquisition or Disposition of Assets

On September 14, 2026, Surgery Partners, Inc. (the "Company"), through certain of its subsidiaries, entered into two Securities Purchase Agreements (the "Agreements") to sell it's ownership interests in Mountain View Hospital, LLC (“MVH”...

20 Aug 2026 Form 4/A: DeLuca Teresa, Director

Bought 11,250 shares ($161K)

19 Aug 2026 Form 4: DeLuca Teresa, Director

Bought 10,000 shares ($144K)

14 Aug 2026 SCHEDULE 13G
10 Aug 2026 FORM 10-Q
10 Aug 2026 8-K: Results of Operations and Financial Condition
24 Jul 2026 8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
14 Jul 2026 Form 4: Hendrix Blair E, Director

Received 34,364 shares as a grant or award ($500K)

09 Jun 2026 Form 4: Hendrix Blair E, Director

Received 11,670 shares as a grant or award ($160K)

09 Jun 2026 Form 4: Deane John A, Director

Received 11,670 shares as a grant or award ($160K)

09 Jun 2026 Form 4: Forese Laura L, Director

Received 11,670 shares as a grant or award ($160K)

09 Jun 2026 Form 4: Adlerz Clifford G, Director

Received 11,670 shares as a grant or award ($160K)

09 Jun 2026 Form 4: Dean Lloyd H, Director

Received 11,670 shares as a grant or award ($160K)

09 Jun 2026 Form 4: DeLuca Teresa, Director

Received 11,670 shares as a grant or award ($160K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support